Reduction of coronavirus burden with mass azithromycin distribution. (COVID special issue #2.)
Clinical Infectious Diseases
; 71(16):2282-2284, 2020.
Article
in English
| CAB Abstracts | ID: covidwho-1165368
ABSTRACT
We evaluated the potential antiviral effects of azithromycin on the nasopharyngeal virome of Nigerien children who had received multiple rounds of mass drug administration. We found that the respiratory burden of non-severe acute respiratory syndrome coronaviruses was decreased with azithromycin distributions.
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
English
Journal:
Clinical Infectious Diseases
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS